VITASOY INT'L(HK:00345) Zheng Quan Shi Bao Wang·2025-06-24 10:56Group 1 - The core viewpoint of the article highlights Vitasoy International's revenue growth of 1% for the fiscal year 2024/2025, reaching HKD 6.274 billion, driven by strong performance in core products in mainland China and stable results in Hong Kong [1] - The company's net profit attributable to equity holders surged by 102% to HKD 235 million, attributed to improved sales execution in mainland China and strong performance in Hong Kong [1] - The company plans to distribute a final dividend of HKD 0.102 per share, pending approval at the annual general meeting on August 25, 2025, resulting in a total dividend of HKD 0.142 per share for the fiscal year 2024/2025, compared to HKD 0.077 per share in the previous fiscal year [1] Group 2 - Vitasoy International aims to maintain business scale and profitability across all operating units while focusing on expanding market share in core products like plant-based milk and ready-to-drink tea, particularly in mainland China [2] - The company acknowledges challenges from a worsening external environment and slowing growth in various product categories but remains confident in its core product portfolio and health innovation series to capture growth opportunities [2]